Alexium Worldwide Expands with Strategic Acquisition » BedTimes Journal
(GREER, SC — December 15, 2025) — Alexium Worldwide Group Restricted (ASX:AJX, “Alexium”), a chief in superior phase-change materials (PCM) methods and flame-retardant (FR) chemistries, at present introduced its acquisition of Microtek Laboratories (“Microtek”) from CAVU Group in trade for shares in Alexium. The acquisition considerably expands Alexium’s thermal-management platform and contains Microtek’s full microencapsulation and PCM enterprise, together with the related mental property. Microtek’s temperature-controlled packaging division (Adaptek™) is excluded from the transaction and stays beneath CAVU Group possession. All Microtek merchandise will proceed to be manufactured in Dayton, OH and will likely be built-in into Alexium’s choices with out interruption.
The acquisition brings collectively two of the business’s most established innovators in microencapsulation and PCM chemistry. Integrating Microtek’s state-of-the-art manufacturing plant, formulations, and many years of encapsulation experience into Alexium’s vertically built-in U.S. operations enhances home manufacturing functionality, strengthens supply-chain resiliency, and expands the mixed know-how portfolio.
The mixed manufacturing capability positions the unified enterprise to ship stronger manufacturing continuity, improved lead instances, and better management over high quality and scale for patrons of each firms.
“Bringing Microtek’s microencapsulation and PCM applied sciences—and their manufacturing services—into the Alexium household accelerates our potential to ship high-performance cooling options with unmatched reliability,” mentioned Billy Blackburn, CEO of Alexium Worldwide. “This acquisition broadens our technical capabilities and meaningfully strengthens our U.S. provide chain, benefiting each Microtek and Alexium clients with better stability, responsiveness, and scalability. We intend to proceed operations in Dayton and to serve Microtek’s current buyer base with none interruption.”
Microtek Laboratories has lengthy been acknowledged as a pioneer in microencapsulated PCM applied sciences, serving markets together with bedding, attire, constructing supplies, and industrial purposes. Its processes, formulations, IP, and flagship NexTek™ and Micronal® product strains complement Alexium’s current portfolio, together with BioCool®, Alexicool®, DelCool™, AlexiShield, and Eclipsys®, making a extra complete platform for foam, textile, and specialty-materials producers.
“Alexium is an impressive strategic match for Microtek’s PCM and encapsulation enterprise,” mentioned Tim Riazzi of CAVU Group. “Their U.S. manufacturing power, technical depth, and buyer centric strategy guarantee Microtek’s applied sciences will proceed to develop, scale, and ship worth to the markets we’ve served for greater than three many years.”
Collectively, the corporate will function with expanded capability and broader innovation pathways, providing vital benefits to formulators buying microcapsules as intermediates in addition to producers sourcing completed PCMs and flame-retardant options. The mixed product breadth and unified R&D roadmap create a stronger basis for next-generation microencapsulation and consolation applied sciences.
Going ahead, all industrial operations, gross sales, and go-to-market actions for the mixed entity will likely be performed beneath the Alexium Worldwide entity. It stays enterprise as common for all Microtek clients: each Microtek PCM and microencapsulation product stays absolutely out there, now supported by Alexium’s expanded U.S. manufacturing footprint with enhanced provide stability, and devoted buyer assist crew. For extra data, contact [email protected].
